Xencor Inc (XNCR)
18.37
-0.61
(-3.21%)
USD |
NASDAQ |
Apr 19, 16:00
18.37
0.00 (0.00%)
After-Hours: 20:00
Xencor Cash from Operations (TTM): 85.11M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 85.11M |
September 30, 2023 | -120.53M |
June 30, 2023 | -94.41M |
March 31, 2023 | -11.94M |
December 31, 2022 | 24.48M |
September 30, 2022 | 110.71M |
June 30, 2022 | 72.85M |
March 31, 2022 | 18.93M |
December 31, 2021 | -16.85M |
September 30, 2021 | -61.56M |
June 30, 2021 | -26.40M |
March 31, 2021 | -44.43M |
December 31, 2020 | -5.004M |
September 30, 2020 | -41.66M |
June 30, 2020 | -44.28M |
March 31, 2020 | 92.56M |
December 31, 2019 | 64.37M |
September 30, 2019 | 67.17M |
June 30, 2019 | 63.34M |
March 31, 2019 | -74.24M |
December 31, 2018 | -79.76M |
Date | Value |
---|---|
September 30, 2018 | -69.64M |
June 30, 2018 | -62.84M |
March 31, 2018 | -47.30M |
December 31, 2017 | -33.60M |
September 30, 2017 | -42.10M |
June 30, 2017 | 95.48M |
March 31, 2017 | 98.99M |
December 31, 2016 | 95.24M |
September 30, 2016 | 106.56M |
June 30, 2016 | 12.01M |
March 31, 2016 | 14.46M |
December 31, 2015 | 26.67M |
September 30, 2015 | 24.65M |
June 30, 2015 | -19.59M |
March 31, 2015 | -18.45M |
December 31, 2014 | -21.35M |
September 30, 2014 | -19.64M |
June 30, 2014 | -19.03M |
March 31, 2014 | -12.09M |
December 31, 2013 | -5.453M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-120.53M
Minimum
Sep 2023
110.71M
Maximum
Sep 2022
6.971M
Average
-5.004M
Median
Dec 2020
Cash from Operations (TTM) Benchmarks
Ionis Pharmaceuticals Inc | -307.51M |
Karyopharm Therapeutics Inc | -92.72M |
NovaBay Pharmaceuticals Inc | -4.131M |
Palatin Technologies Inc | -26.54M |
iBio Inc | -18.89M |